125 related articles for article (PubMed ID: 2043128)
1. Oxidative modification of glycated low density lipoprotein in the presence of iron.
Sakurai T; Kimura S; Nakano M; Kimura H
Biochem Biophys Res Commun; 1991 May; 177(1):433-9. PubMed ID: 2043128
[TBL] [Abstract][Full Text] [Related]
2. Differing effects of probucol and vitamin E on the oxidation of lipoproteins, ceroid accumulation and protein uptake by macrophages.
Hunt JV; Bottoms MA; Taylor SE; Lyell V; Mitchinson MJ
Free Radic Res; 1994 Mar; 20(3):189-201. PubMed ID: 8019642
[TBL] [Abstract][Full Text] [Related]
3. Homocysteine induces iron-catalyzed lipid peroxidation of low-density lipoprotein that is prevented by alpha-tocopherol.
Hirano K; Ogihara T; Miki M; Yasuda H; Tamai H; Kawamura N; Mino M
Free Radic Res; 1994 Oct; 21(5):267-76. PubMed ID: 7842136
[TBL] [Abstract][Full Text] [Related]
4. The oxidative modification of low density lipoprotein by nonenzymatically glycated peptide-Fe complex.
Sakurai T; Kimura S; Nakano M; Kimura H
Biochim Biophys Acta; 1991 Nov; 1086(3):273-8. PubMed ID: 1742318
[TBL] [Abstract][Full Text] [Related]
5. Free and albumin-bound bilirubin are efficient co-antioxidants for alpha-tocopherol, inhibiting plasma and low density lipoprotein lipid peroxidation.
Neuzil J; Stocker R
J Biol Chem; 1994 Jun; 269(24):16712-9. PubMed ID: 8206992
[TBL] [Abstract][Full Text] [Related]
6. Preservation of the endogenous antioxidants in low density lipoprotein by ascorbate but not probucol during oxidative modification.
Jialal I; Grundy SM
J Clin Invest; 1991 Feb; 87(2):597-601. PubMed ID: 1991843
[TBL] [Abstract][Full Text] [Related]
7. Concentration-dependent antioxidant activity of probucol in low density lipoproteins in vitro: probucol degradation precedes lipoprotein oxidation.
Barnhart RL; Busch SJ; Jackson RL
J Lipid Res; 1989 Nov; 30(11):1703-10. PubMed ID: 2614272
[TBL] [Abstract][Full Text] [Related]
8. The role of copper reduction by alpha-tocopherol in low-density lipoprotein oxidation.
Proudfoot JM; Croft KD; Puddey IB; Beilin LJ
Free Radic Biol Med; 1997; 23(5):720-8. PubMed ID: 9296448
[TBL] [Abstract][Full Text] [Related]
9. Indications for the presence of circulating peroxidized low density lipoproteins in WHHL rabbits treated with antioxidants.
Demacker PN; Hijmans AG; Kleinveld HA; Stalenhoef AF
Atherosclerosis; 1993 Aug; 102(1):69-77. PubMed ID: 8257454
[TBL] [Abstract][Full Text] [Related]
10. Dietary antioxidant inhibits lipoprotein oxidation and renal injury in experimental focal segmental glomerulosclerosis.
Lee HS; Jeong JY; Kim BC; Kim YS; Zhang YZ; Chung HK
Kidney Int; 1997 Apr; 51(4):1151-9. PubMed ID: 9083281
[TBL] [Abstract][Full Text] [Related]
11. Why is glycated LDL more sensitive to oxidation than native LDL? A comparative study.
Sobal G; Menzel J; Sinzinger H
Prostaglandins Leukot Essent Fatty Acids; 2000 Oct; 63(4):177-86. PubMed ID: 11049692
[TBL] [Abstract][Full Text] [Related]
12. In vitro and ex vivo inhibition of the modification of low-density lipoprotein by indapamide.
Breugnot C; Iliou JP; Privat S; Robin F; Vilaine JP; Lenaers A
J Cardiovasc Pharmacol; 1992 Sep; 20(3):340-7. PubMed ID: 1279277
[TBL] [Abstract][Full Text] [Related]
13. Tyrosyl radical generated by myeloperoxidase is a physiological catalyst for the initiation of lipid peroxidation in low density lipoprotein.
Savenkova ML; Mueller DM; Heinecke JW
J Biol Chem; 1994 Aug; 269(32):20394-400. PubMed ID: 8051134
[TBL] [Abstract][Full Text] [Related]
14. Antioxidant BO-653 and human macrophage-mediated LDL oxidation.
Müller K; Carpenter KL; Freeman MA; Mitchinson MJ
Free Radic Res; 1999 Jan; 30(1):59-71. PubMed ID: 10193574
[TBL] [Abstract][Full Text] [Related]
15. A critical assessment of the effects of aminoguanidine and ascorbate on the oxidative modification of LDL: evidence for interference with some assays of lipoprotein oxidation by aminoguanidine.
Scaccini C; Chiesa G; Jialal I
J Lipid Res; 1994 Jun; 35(6):1085-92. PubMed ID: 8077847
[TBL] [Abstract][Full Text] [Related]
16. Antioxidants decreases the intensification of low density lipoprotein in vivo peroxidation during therapy with statins.
Lankin VZ; Tikhaze AK; Kukharchuk VV; Konovalova GG; Pisarenko OI; Kaminnyi AI; Shumaev KB; Belenkov YN
Mol Cell Biochem; 2003 Jul; 249(1-2):129-40. PubMed ID: 12956408
[TBL] [Abstract][Full Text] [Related]
17. Increased oxidizability of plasma lipoproteins in diabetic patients can be decreased by probucol therapy and is not due to glycation.
Babiy AV; Gebicki JM; Sullivan DR; Willey K
Biochem Pharmacol; 1992 Mar; 43(5):995-1000. PubMed ID: 1554398
[TBL] [Abstract][Full Text] [Related]
18. Antioxidant effect of probucol on RO2*/O2(*-)-induced peroxidation of human low-density lipoproteins.
Bonnefont-Rousselot D; Segaud C; Jore D; Delattre J; Gardès-Albert M
Radiat Res; 1999 Mar; 151(3):343-53. PubMed ID: 10073673
[TBL] [Abstract][Full Text] [Related]
19. The influence of magnesium-pyridoxal-5'-phosphate-glutamate in comparison with probucol, alpha-tocopherol and trolox on copper-induced oxidation of human low density lipoprotein in vitro.
Kögl C; Schneider W; Elstner EF
Biochem Pharmacol; 1994 Jun; 47(12):2201-6. PubMed ID: 8031313
[TBL] [Abstract][Full Text] [Related]
20. Ultraviolet-treated lipoproteins as a model system for the study of the biological effects of lipid peroxides on cultured cells. III. The protective effect of antioxidants (probucol, catechin, vitamin E) against the cytotoxicity of oxidized LDL occurs in two different ways.
Negre-Salvayre A; Alomar Y; Troly M; Salvayre R
Biochim Biophys Acta; 1991 Jun; 1096(4):291-300. PubMed ID: 2065102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
